ARTICLE | Top Story
Takeda to acquire Intellikine
December 21, 2011 1:52 AM UTC
Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) will acquire cancer company Intellikine Inc. (La Jolla, Calif.) for $190 million up front and up to $120 million in milestones. Takeda will gain Intellikine...